The biggest problem in China's medical informatization is that IT people do medical treatment.
Release date: 2014-06-11 On June 7, 2014, the Shanghai Roundtable on Health Policy, hosted by China Europe International Business School, was held in the eighth session of the Shanghai Round Table on Health Policy. The theme of the conference was "Information Technology, Subversion of Health", and Multiple Health Policy research experts, medical and health providers, and government health policy decision makers conduct in-depth discussions and research on this topic. The following is a wonderful speech that intercepted some of the guests. Speaker: Xie Zhenzhong, Director of Management Consulting, Accenture Greater China Medical and Public Sector The general direction of medical information planning is correct, but it is very bad at the implementation level, especially from the Ministry of Health to the provincial and municipal levels, and even some policies have problems at the ministerial level. Why can't I use my ID card? In fact, the ID card can always be used, it is not impossible to use, and the ID card is a very important thing. When you enter the ID number, everything comes out. Why can't I use it? Because there are too many stakeholders, this is also a Chinese characteristic. For example, in the United States, there are many commercial insurance groups in the United States. He has his own system, so his payment process is very convenient. But in China, we have to pay. For example, we use safe insurance for Accenture. He relies on the bills that the hospital started. The biggest problem in China's medical treatment now is the payment . Our Ministry of Health is going to pay for medical expenses, but the medical insurance is under the supervision of the Ministry of Health. Health policies require multiple ministries and commissions, and policies are more confusing. We have introduced many multinational groups into China. They asked us how can you make such a plan in China and make the entire industrial chain of the medical industry? Why can't you do it in the US? Because the US interest group has already divided up. Therefore, China's informationization is very large and can be. Now more information is being used by doctors, not by doctors. Now the biggest problem with medical IT is that many IT people are doing medical things, not medical people doing IT. This is the biggest problem. Foreign companies still have some advantages in the medical information market. I think there is an opportunity for foreign investment, but in the case of foreign investment in the past two years, opportunities are limited. Especially in the current situation, if foreign companies compete with Chinese companies, the risks are high. Because I am responsible for the Greater China market, we know that China has a lot of means of operation, and there are countermeasures under the policy. But the competition in the market like medical informatization is very intense. I think foreign companies should recognize their strengths. For example, when McKinsey first sold information asymmetry, foreign things you don't know, I know, so I sell it to you. It is no longer possible now. Therefore, we must introduce a lot of foreign resources, what resources do you lack, I will help you introduce. (Furthermore), many foreign medical institutions have experienced several years. What is Accenture doing now? We integrate various resources, because Accenture is the only pure service company among the top 500, there is no product, so any resources can be integrated into our platform. So, like a product-oriented enterprise, I suggest that you still create some The market comes out, otherwise if you simply do it, everyone knows that the copying ability of Chinese companies is very strong. If he learns you 60%, 70%, you can't compete with him because your cost must be better than him. high. In addition, in China to buy information systems, many deans think it is unnecessary. Therefore, my suggestion must be to find the company's own business model, rather than saying that I have a product to be a product company, of course, how to design a business model, this is the problem of the enterprise itself. ã€Comment】 Who is suitable for medical informationization? The public said that the public is reasonable, and the woman said that she is reasonable. Although Accenture’s words will cause controversy, it is not difficult to see that it stands in its own business perspective. In the face of a huge market like China, which multinational companies are willing to let go, and the downside of domestic enterprises? Source: Sohu Health China Extract Powder For Use As Dietary Supplement Extract Powder, Extract Powder Manufacturer Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.apipepdites.com